ESWI activities

ESWI Science Policy Interface Roundtable in Bucharest
22 October 2026
Bucharest, Romania
This event will bring together key stakeholders to address the critical challenges surrounding vaccine uptake and public health policy.
Spotlight on the Interdisciplinary Disease Collaboration on Respiratory Infections and NCDs (IDC)
Tune in to this extraordinary conversation exploring the important interplay between respiratory viruses and non-communicable diseases like diabetes, obesity, and cardiovascular disease
ESWI Airborne: Shaping the Future of Respiratory Virus Research
Tune in to the new ESWI podcast podcast series featuring Early Career Scientist featuring researchers who will help shape the next decades of influenza and respiratory virus research.
ESWI Summit 2026
11 June 2026
The ESWI Respiratory Virus Summit will take place on 11 June in Brussels.

Agenda

2026
28
January
Epidemiology and Policy Advocacy to Support Vaccine and Anti-Viral Uptake for Respiratory Pathogens - APACI webinar
Online
Join the APACI 2026 Respiratory diseases webinar on 28 January 2026, 9am – 12pm HK time, exploring epidemiology and policy advocacy to support vaccine and anti viral uptake for respiratory pathogens.
2026
17-20
February
RSVVW’26
Rome, Italy
ReSViNET is the first official RSV foundation and aims to provide a platform for global collaborations to raise awareness about RSV infection.
2026
27-28
February
Travel Medicine Review and Update Course
Online
This course is tailored for physicians, nurses, and healthcare professionals who provide care and advice to travelers, expatriates, and migrants.
2026
2-4
March
8th International Forum on Respiratory Tract Infections
Glasgow, Scotland
The 8th International Forum on Respiratory Tract Infections (RTI) will be held from March 2-4, 2026, at the Glasgow Science Centre in Glasgow, Scotland.
2026
2-3
March
International Science Innovation Week 2026
International Science Innovation Week 2026 will convene world leaders in science, medicine, and innovation to advance collaboration in pandemic preparedness, virology, and cancer research.
2026
1-5
June
ESPID 2026
Bologna, Italy & Online
44th European Society of Paediatric Infectious Diseases Meeting

Education hub

Scientific Papers
Population effects of influenza vaccination in children and adolescents: Systematic review
To investigate indirect vaccine effectiveness (indirVE) of vaccination of children and adolescents with seasonal influenza vaccines against influenza-related outcomes occurring in other population groups.
News
Call for Action: Life Course Immunisation Strategy
A Seamless Approach to Protection Across All Ages and Risk Groups
Scientific Papers
Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24
Baloxavir marboxil, a cap-dependent endonuclease inhibitor, was approved in Japan in February 2018 for treatment of influenza A and B infections, making Japan the first country to introduce its clinical use.
News
Molecular basis of 60 years of antigenic evolution of human influenza A(H3N2) virus neuraminidase
Human influenza A viruses escape antibody-mediated immunity through changes in the hemagglutinin (HA) and neuraminidase (NA) glycoproteins.

ESWI networks & communities

Interdisciplinary Disease Collaboration

on Respiratory Infections and Non-communicable diseases

The Interdisciplinary Disease Collaboration on Respiratory Infections and Non-communicable diseases (IDC) unites scientists, healthcare professionals, patient -and other stakeholder organisations to achieve a better understanding of the bidirectional relationship and causal links between acute respiratory infections and non-communicable diseases.

Early Career Scientists Network

Some of the best and most innovative ideas come from early career scientists, they are the future of the influenza field. For this reason, ESWI has been actively encouraging the careers of early career scientists for many years.